Melissa H.S. Roeffen

13 papers receiving 336 citations

Peers

Melissa H.S. Roeffen
Comparison fields: 5 of 48
  • Molecular Biology 181
  • Pulmonary and Respiratory Medicine 162
  • Oncology 96
  • Pathology and Forensic Medicine 71
  • Cancer Research 52
Replace Nabahet Ameur with:
Nabahet Ameur France
Hang‐bo Zhou China
Kotaro Mizuno Japan
Lucie Coppin France
J. Küster Germany
Francesca Garbini Italy
Érica Boldrini Brazil
Paul Waring Australia
Cameron G. Binnie United States
Violette Shahbazian United States
Melissa H.S. Roeffen relative to Nabahet Ameur France Nabahet Ameur's profile →
Citations per field
00.5×1.5×2.4×
Nabahet Ameur · 1×
Citations per year

Countries citing papers authored by Melissa H.S. Roeffen

Since Specialization
Citations

This map shows the geographic impact of Melissa H.S. Roeffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa H.S. Roeffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa H.S. Roeffen more than expected).

Fields of papers citing papers by Melissa H.S. Roeffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa H.S. Roeffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa H.S. Roeffen. The network helps show where Melissa H.S. Roeffen may publish in the future.

Co-authorship network of co-authors of Melissa H.S. Roeffen

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa H.S. Roeffen. A scholar is included among the top collaborators of Melissa H.S. Roeffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa H.S. Roeffen. Melissa H.S. Roeffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 17
2 34
3 19
4 10
5 3
6 7
7 3
8 47
9 2
10 37
11 92
12 2
13 66

About Melissa H.S. Roeffen

Melissa H.S. Roeffen is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 13 papers that have together received 339 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Lymphoma Diagnosis and Treatment (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (162 citations), Pathology and Forensic Medicine (71 citations) and Oncology (96 citations). Melissa H.S. Roeffen has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Winette T.A. van der Graaf, Yvonne M.H. Versleijen‐Jonkers, Uta Flucke, Albert J.H. Suurmeijer, Eveline S.J.M. de Bont, Emmy D.G. Fleuren, Otto C. Boerman, Stefan Sleijfer, Annelies M. C. Mavinkurve‐Groothuis and H.W.B. Schreuder. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026